February 6, 2020

Tracking allergies through Medsmart®

peanut allergy

It is so important for people to be able to track allergies. Around 2-4% of children in the UK have a peanut allergy. This can result in skin reactions, itching, tightening of the throat and many other symptoms. These side effects can hugely affect how individuals live their day to day lives. This could be through avoiding restaurants or holidays in fear of an allergic reaction.

In the news the FDA has now approved a new peanut allergy treatment. The drug, known as Palforzia®. It uses oral immunotherapy and will be administered in increasing amounts over the course of half a year. After this time the dose will drop to a maintenance amount.

Using our Medsmart® app users can track ingredients to understand what is in their medicines. By understanding patients who have allergies we can help you deliver more effective educational content to those who need it.

Please get in touch if you would like to hear more about how our data products and how it can help you uncover the patient voice and proactively engage with your medicine users in the area of allergies.

 

THE TALKING MEDICINES BLOG

Keeping In-Pharmed

Keeping In-Pharmed

As a technology business with a focus on providing pharma marketers with data-based patient intelligence, it’s vital that we stay on top of the big...

read more